Titan Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	18.73	55.58	32.86	48.64	68.14
Cash & Short-Term Investments	18.73	55.58	32.86	48.64	68.14
Cash Growth	-66.30%	69.18%	-32.45%	-28.62%	25.01%
Accounts Receivable	228.29	188.16	186.58	210.08	163.59
Receivables	228.29	188.16	186.58	210.08	163.59
Inventory	557.69	507.23	455.71	361.7	346.8
Prepaid Expenses	-	3.17	1.87	1.23	-
Other Current Assets	47.72	36.23	49.18	61.42	59.03
Total Current Assets	852.43	790.38	726.2	683.06	637.56
Property, Plant & Equipment	632.52	588.46	544.7	491.04	385.15
Long-Term Investments	603.63	347.91	285.48	156.69	40.31
Other Intangible Assets	0.84	1.22	0.95	0.85	1.05
Other Long-Term Assets	49.44	19.11	12.93	13.52	16.85
Total Assets	2,139	1,747	1,570	1,345	1,081
Accounts Payable	85.41	52.17	33.68	55.5	41.6
Accrued Expenses	8.69	72.46	66.46	55.51	39.37
Short-Term Debt	33.44	19.18	67.18	67	64.5
Current Portion of Leases	5.93	8.9	8.83	3.81	2.9
Current Income Taxes Payable	12.66	-	-	0.29	3.14
Other Current Liabilities	113.5	24.66	19.56	21.41	17.99
Total Current Liabilities	259.63	177.36	195.71	203.51	169.49
Long-Term Debt	3.27	1.84	4.53	2.99	10.81
Long-Term Leases	14.43	2.35	6.94	11.32	11.09
Pension & Post-Retirement Benefits	22.79	16.28	14.83	16.15	14.33
Long-Term Deferred Tax Liabilities	23.26	15.21	13.72	12.07	12.76
Total Liabilities	323.37	213.04	235.74	246.04	218.47
Common Stock	82.64	82.64	82.64	82.64	82.64
Additional Paid-In Capital	-	86.75	86.75	86.75	86.75
Retained Earnings	-	1,361	1,162	928.21	692.17
Comprehensive Income & Other	1,733	3.99	3.26	1.51	0.89
Total Common Equity	1,815	1,534	1,335	1,099	862.44
Shareholders' Equity	1,815	1,534	1,335	1,099	862.44
Total Liabilities & Equity	2,139	1,747	1,570	1,345	1,081
Total Debt	57.07	32.27	87.48	85.12	89.3
Net Cash (Debt)	-38.34	23.31	-54.63	-36.48	-21.16
Net Cash Per Share	-0.93	0.56	-1.32	-0.88	-0.51
Filing Date Shares Outstanding	41.32	41.32	41.32	41.32	41.32
Total Common Shares Outstanding	41.32	41.32	41.32	41.32	41.32
Working Capital	592.8	613.02	530.49	479.55	468.06
Book Value Per Share	43.94	37.13	32.30	26.60	20.87
Tangible Book Value	1,815	1,533	1,334	1,098	861.4
Tangible Book Value Per Share	43.92	37.10	32.28	26.58	20.85
Buildings	-	218.37	207.56	130.34	130.25
Machinery	-	474.05	391.37	281.77	254.21
Construction In Progress	-	16.84	25.32	132.94	36.34